Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Panitumumab and Chemotherapy in Locally Advanced Colon Cancer
NCT01108107Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Apr 2010
- Primary completion
- Sep 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colon cancer, sponsored by Vejle Hospital. Started Apr 2010; status: completed.
02
Drugs
panitumumab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01108107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108107.